formulation of semaglutide due to its demonstrated efficacy over other glucose-lowering agents, including orally administered semaglutide [1, 2]
Its lipid profile is characterized by a high proportion of polyunsaturated fatty acids (PUFAs), particularly linolenic acid, which accounts for approximately 36% of its total fatty acid content (Diniz et al., 2024)
10.1021/acsmedchemlett.6b00060 Summary Keywords glutamine, glutamine metabolism, glutamine uptake, cancer therapy, combination therapy Citation Fan Y, Xue H, Li Z, Huo M, Gao H and Guan X (2024) Exploiting the Achilles heel of cancer: disrupting glutamine metabolism for effective cancer treatment
10.1002/jbt.21977 49 TacarO.SriamornsakP.DassC